Health

HPV vaccine approved for people through age 45

(HealthDay)—U.S. Food and Drug Administration approval of the Gardasil 9 human papillomavirus (HPV) vaccine has been expanded to include people ages 27 through 45, the agency said in a news release.

Oncology & Cancer

Cancer in Europe: more cases but fewer deaths

The number of cancer cases has continued to rise across Europe, however mortality rates from the disease have fallen, according to the World Health Organization's "European Health Report", published Wednesday.

Oncology & Cancer

In US, HPV-related cancers on rise

Despite rising vaccination rates, cancers related to human papillomavirus, a common sexually transmitted infection, are on the rise in the United States, particularly cancers of the head, neck and throat, officials said Thursday.

Oncology & Cancer

Annual pap test a 'thing of the past?'

The United States Preventive Services Task Force (USPSTF) has released new recommendations on screening for cervical cancer. These latest recommendations continue the trend of decreasing participant burden by lengthening ...

page 37 from 40